Sinopharm (1099.HK) Financial Analysis & Valuation | Quarter Chart
Sinopharm (1099.HK)
1099.HKPrice: $2.19
Fair Value: 🔒
🔒score
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmac... more
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pha... more
Description
Shares
| Market Cap | $6.83B | Exchange | HKSE |
| Sector | Healthcare | Industry | Medical - Distribution |
| Country | CN | CEO | Wanyong Lian |
| IPO Date | 2009-09-23 | CAGR | 0.18% |
| Employees | 108,217 | Website | www.sinopharmgroup.com.cn |
| Div. Yield | 5.06% | Payout Ratio | 0.59% |
| Buy Back Yield | — | Total Yield | 5.06% |
1099.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $101.55B | P/E Ratio | 6.47 |
| Forward P/E | 6.42 | PEG Ratio | -1.5 |
| P/S Ratio | 0.08 | P/B Ratio | 0.47 |
| P/CF Ratio | 3.28 | P/FCF Ratio | 3.75 |
| EPS | $0.34 | EPS Growth 1Y | -19.47% |
| EPS Growth 3Y | 12.07% | EPS Growth 5Y | 84.21% |
| Revenue Growth 1Y | 15.53% | Gross Margin | 0.07% |
| Operating Margin | 0.03% | Profit Margin | 0.01% |
| ROE | 0.09% | ROA | 0.02% |
| ROCE | 0.11% | Current Ratio | 1.41 |
| Quick Ratio | 1.15 | Cash Ratio | 0.25 |
| Debt/Equity | 1.29 | Interest Coverage | 9.36 |
| Altman Z Score | 3.89 | Piotroski Score | 7 |